Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ADAPYADAPY
Showing 6 of 29 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$132,866

Total Shares Change

-139,801

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.03
0
2025-Q3
Unchanged
67,032
0.0%
$8,7140.0%$0.14
0
2025-Q2
Decreased
67,032
-38.5%
$16,0670.0%$0.25
0
2025-Q1
Decreased
109,066
-22.0%
$21,4860.0%$0.21
0
2024-Q4
Unchanged
139,801
0.0%
$75,3100.0%$0.55
0
2024-Q3
Increased
139,801
+18.6%
$132,8660.0%$0.98
18

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used